David E. Bush, Ph.D. - Publications

Affiliations: 
2004 University of Toronto, Toronto, ON, Canada 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Debiec J, Diaz-Mataix L, Bush DE, Doyère V, LeDoux JE. The selectivity of aversive memory reconsolidation and extinction processes depends on the initial encoding of the Pavlovian association. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 695-9. PMID 24255099 DOI: 10.1101/lm.031609.113  1
2013 Cowansage KK, Bush DE, Josselyn SA, Klann E, Ledoux JE. Basal variability in CREB phosphorylation predicts trait-like differences in amygdala-dependent memory. Proceedings of the National Academy of Sciences of the United States of America. 110: 16645-50. PMID 24062441 DOI: 10.1073/pnas.1304665110  1
2013 Galatzer-Levy IR, Bonanno GA, Bush DE, Ledoux JE. Heterogeneity in threat extinction learning: substantive and methodological considerations for identifying individual difference in response to stress. Frontiers in Behavioral Neuroscience. 7: 55. PMID 23754992 DOI: 10.3389/fnbeh.2013.00055  1
2013 Isogawa K, Bush DE, LeDoux JE. Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression. Biological Psychiatry. 73: 353-9. PMID 23036960 DOI: 10.1016/j.biopsych.2012.08.021  1
2012 Erlich JC, Bush DE, Ledoux JE. The role of the lateral amygdala in the retrieval and maintenance of fear-memories formed by repeated probabilistic reinforcement. Frontiers in Behavioral Neuroscience. 6: 16. PMID 22514524 DOI: 10.3389/fnbeh.2012.00016  1
2011 DÄ™biec J, Bush DE, LeDoux JE. Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats--a possible mechanism for the persistence of traumatic memories in PTSD. Depression and Anxiety. 28: 186-93. PMID 21394851 DOI: 10.1002/da.20803  1
2010 Bush DE, Caparosa EM, Gekker A, Ledoux J. Beta-adrenergic receptors in the lateral nucleus of the amygdala contribute to the acquisition but not the consolidation of auditory fear conditioning. Frontiers in Behavioral Neuroscience. 4: 154. PMID 21152344 DOI: 10.3389/fnbeh.2010.00154  1
2010 Debiec J, Díaz-Mataix L, Bush DE, Doyère V, Ledoux JE. The amygdala encodes specific sensory features of an aversive reinforcer. Nature Neuroscience. 13: 536-7. PMID 20348916 DOI: 10.1038/nn.2520  1
2009 Sotres-Bayon F, Diaz-Mataix L, Bush DE, LeDoux JE. Dissociable roles for the ventromedial prefrontal cortex and amygdala in fear extinction: NR2B contribution. Cerebral Cortex (New York, N.Y. : 1991). 19: 474-82. PMID 18562331 DOI: 10.1093/cercor/bhn099  1
2007 Bush DE, Sotres-Bayon F, LeDoux JE. Individual differences in fear: isolating fear reactivity and fear recovery phenotypes. Journal of Traumatic Stress. 20: 413-22. PMID 17721971 DOI: 10.1002/jts.20261  1
2007 Bush DE, Vaccarino FJ. Individual differences in elevated plus-maze exploration predicted progressive-ratio cocaine self-administration break points in Wistar rats. Psychopharmacology. 194: 211-9. PMID 17581743 DOI: 10.1007/s00213-007-0835-7  1
2007 Burghardt NS, Bush DE, McEwen BS, LeDoux JE. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biological Psychiatry. 62: 1111-8. PMID 17524369 DOI: 10.1016/j.biopsych.2006.11.023  1
2007 Sotres-Bayon F, Bush DE, LeDoux JE. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1929-40. PMID 17213844 DOI: 10.1038/sj.npp.1301316  1
2007 Kopec CD, Kessels HW, Bush DE, Cain CK, LeDoux JE, Malinow R. A robust automated method to analyze rodent motion during fear conditioning. Neuropharmacology. 52: 228-33. PMID 16926033 DOI: 10.1016/j.neuropharm.2006.07.028  1
2004 Sotres-Bayon F, Bush DE, LeDoux JE. Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learning & Memory (Cold Spring Harbor, N.Y.). 11: 525-35. PMID 15466303 DOI: 10.1101/lm.79504  1
2004 Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience. 128: 7-14. PMID 15450349 DOI: 10.1016/j.neuroscience.2004.06.015  1
2004 Wunderlich GR, Rotzinger S, Bush DE, DeSousa NJ, Vaccarino FJ. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure. Brain Research. 1001: 95-107. PMID 14972658 DOI: 10.1016/j.brainres.2003.10.064  1
2002 Rotzinger S, Bush DE, Vaccarino FJ. Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour. Pharmacology & Toxicology. 91: 404-13. PMID 12688386 DOI: 10.1034/j.1600-0773.2002.910620.x  1
2001 Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G. Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods (San Diego, Calif.). 23: 11-20. PMID 11162146 DOI: 10.1006/meth.2000.1102  1
2000 DeSousa NJ, Bush DE, Vaccarino FJ. Self-administration of intravenous amphetamine is predicted by individual differences in sucrose feeding in rats. Psychopharmacology. 148: 52-8. PMID 10663417  1
1999 Bush DE, DeSousa NJ, Vaccarino FJ. Self-administration of intravenous amphetamine: effect of nucleus accumbens CCKB receptor activation on fixed-ratio responding. Psychopharmacology. 147: 331-4. PMID 10639694 DOI: 10.1007/s002130051176  1
1995 Josselyn SA, Frankland PW, Petrisano S, Bush DE, Yeomans JS, Vaccarino FJ. The CCKB antagonist, L-365,260, attenuates fear-potentiated startle. Peptides. 16: 1313-5. PMID 8545257 DOI: 10.1016/0196-9781(95)02013-M  1
Show low-probability matches.